Keep out of reach of children. Read the manual carefully before use
If need more information please consult with your doctor
INDICATION:
Active duodenal ulcer
Active benign gastric ulcer
Symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).
Gastro-oesophageal reflux disease, long-term management (GORD maintenance)
Symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic GORD)
Zollinger-Ellison Syndrome
In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease
DOSAGE AND APPLICATION:
Dosage
Adults and the elderly:
Active duodenal ulcer and active benign gastric ulcer:
The recommended oral daily dose for active duodenal ulcer and active benign gastric ulcer is 20 mg daily taken in the morning.
Most patients with active duodenal ulcers recover within four weeks. Some are difficult to heal however, the patient may need an additional four weeks of additional treatment to achieve recovery in order to.
Most patients with active benign gastric ulcers recover within six weeks. Some hard, however, a recovering patient may need an additional six weeks of additional treatment to achieve recovery in order to.
Erosive or ulcerative gastro-oesophageal reflux diseases (GORD):
In this condition, the recommended oral dose is 20 mg daily for 4-8 weeks.
Long-term treatment of gastro-oesophageal reflux disease (GORD maintenance treatment):
For long-term treatment, the maintenance dose of Gelbra is 20 mg or 10 mg a day depending on your response.
Symptomatic treatment of moderate to severe gastro-oesophageal reflux disease (symptomatic GORD treatment) :
For patients without esophagitis, 10 mg daily. If within four weeks the symptoms fail further examination of the patient is required. After the symptoms have disappeared, additional symptoms control with an appropriate dose of 10 mg once daily if necessary can be kept.
Zollinger-Ellison syndrome:
The recommended starting dose for adults is 60 mg daily. If necessary, the daily dose is up to 120 mg individually can be raised. The single daily dose should not exceed 100 mg. If 120 mg daily is required. It is recommended that the dose be taken in two divided doses of 60 mg twice daily. Treatment should be continued for as long as possible it is clinically warranted.
Helicobacter pylori eradication:
The Helicobacter pylori in patients infected with H. pylori eradication therapy is needed. The below combination is recommended for 7 days.
Gelbra 20 mg twice daily + 500 mg clarithromycin twice daily and 1 g twice daily amoxicillin.
Patients with renal or hepatic impairment:
No dose adjustment is required in patients with renal or hepatic impairment
Children and adolescents:
Gelbra is not recommended for use in children as there is insufficient experience with this age group.
Method of application
For indications where Gelbra tablets should be taken once daily, it is advisable to take them in the morning. before meals, although neither the time of day nor the meal affects rabeprazole sodium activity, however, results in better patient cooperation during treatment.
The patient should be advised not to chew or crush the Gelbra tablet. but should be swallowed whole.
CONTRAINDICATIONS:
Gelbra is contra-indicated in pregnancy and during breastfeeding
OTHER INFORMATION: Please refer to the Instruction sheet included in the package
MANUFACTURER: MEDIPHARCO JOINT-STOCK COMPANY
DISTRIBUTOR: GLOBAL PHARMACEUTICAL JOINT-STOCK COMPANY
